Sunir Garg, MD
Basic profileChief, Retina Service at Wills Eye Hospital · Thomas Jefferson University
Sunir Garg is Chief, Retina Service at Wills Eye Hospital at Thomas Jefferson University. OpenAlex indexes 395 publications with 8,039 citations (h-index 47); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Overview
Updated 20 Oct 2026
Sunir Garg, M.D., is Chief, Retina Service at Wills Eye Hospital. The public record shows 395 publications with 8,064 citations (h-index 47), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Ocular Diseases and Behçet’s Syndrome. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 23 companies.
- Most recent indexed publication: 2026 · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
- Top research focus: Retinal Diseases and Treatments
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 20 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 160.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4060 Butler Pike
Suite 200
Plymouth Meeting, PA 19462-1560
Telephone
800-331-6634Registry record last updated 6 May 2019 · collected 28 Jul 2026.
Clinical trials
Updated 20 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections
Sponsor: MidAtlantic Retina
InvestigatorEarly phase 1UnknownNCT03571100
Industry payments
Updated 20 Oct 2026
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20254 payments$11,478openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20252 payments
- Bausch & Lomb Americas Inc.Program year202514 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
73%Antineovascularisation agents71.4%Faricimab-svoa100%Part B, office-administered≥67 patientsCorticosteroid0.8%Prednisolone Acetate100%Part D≥160 patients+ 6 more classes in this area
Cancer & immunology
22.1%Complement Inhibitor16.4%Pegcetacoplan100%Part B, office-administered≥56 patientsVascular Endothelial Growth Factor Inhibitor5.7%Aflibercept100%Part B, office-administered≥191 patientsDermatology
4.4%Corticosteroid4.4%Triamcinolone acetonide100%Part B, office-administered≥33 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Updated 20 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impact of glaucoma on outcomes after epiretinal membrane surgery. a pairwise and post-hoc single-arm meta-analysis.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Review2026 - Efficacy of Continuous Pegcetacoplan Treatment for Subfoveal Geographic Atrophy in Age-Related Macular Degeneration: 36-Month Results from OAKS, DERBY, and GALE Open-Label Extension.
Clinical ophthalmology (Auckland, N.Z.)
Article2026 - 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2025.
Diabetes care
Review2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Complications of intravitreal injectionsArticle289 citations2010
- 03
- 04
- 05Progression of Geographic Atrophy in Age-related Macular DegenerationArticle219 citations2018
Network
Updated 20 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 20 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/sunir-garg-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
asrs.org/find-a-specialist/profile/1513/Sunir-J-Garg
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Other
willseye.org/doctor/sunir-j-garg-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 20 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →willseye.org ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
Retina Times
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗ - Ophthalmology Editor
Merck Manual
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗ - Member
Editorial Board, American Journal of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗ - Member
Editorial Board, Canadian Journal of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗ - Retina Committee Chair
American Academy of Ophthalmology ONE Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗
- Fellow
American College of Surgeons (FACS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org ↗ - Fellow
American Society of Retina Specialists (FASRS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Secondary affiliations
appointments beyond the home institution- Partner
Mid Atlantic Retina
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Co-director
Retina Research Unit at Wills Eye Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Whellan, MD
Thomas Jefferson University
Jesse Roman, MD
Thomas Jefferson University
Stephen Silberstein, MD
Thomas Jefferson University
David Cognetti, MD
Thomas Jefferson University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”